Literature DB >> 30295217

Circulating maternal and umbilical cord steroid hormone and insulin-like growth factor concentrations in twin and singleton pregnancies.

L C Houghton1, M Lauria2, P Maas3, F Z Stanczyk4, R N Hoover3, R Troisi3.   

Abstract

In addition to being associated with a higher risk of complications during pregnancy, twinning may also be a proxy for altered hormonal exposure for mothers and twin offspring, with implications for their health later in life. We compared maternal and fetal steroid hormone and insulin-like growth factor concentrations between singleton (n=62) and twin (n=41) pregnancies. Maternal concentrations of androgens, estrogens, insulin-like growth factor (IGF)-1, IGF-binding protein (BP)-3 and prolactin were quantified during the third trimester and at delivery, as well as in the fetal circulation at birth. Geometric means accounting for gestational age were calculated for hormone concentrations and compared between matched twin and singleton pregnancies. Most maternal hormone concentrations were modestly higher in twin than in singleton pregnancies in the third trimester (ranging from 8.3% for IGF-1 to 17.1% for estradiol) and at delivery (ranging from 11.1% for IGFBP-3 to 15.2% for estriol). Cord serum hormones were generally similar in twin and singleton pregnancies, except for IGFBP-3, which was 200% lower in twins. The modest differences in maternal hormones in late gestation seem unlikely to explain alterations in hormonally related disease risk in mothers of twins compared with singletons. The large deficit of IGFBP-3 in the fetal circulation of twins at birth may allow for sufficient concentrations of IGF-2 for growth and development in an environment of shared nutritional resources.

Entities:  

Keywords:  IGF-1; androgen; estrogen; pregnancy; twins

Mesh:

Substances:

Year:  2018        PMID: 30295217      PMCID: PMC6453758          DOI: 10.1017/S2040174418000697

Source DB:  PubMed          Journal:  J Dev Orig Health Dis        ISSN: 2040-1744            Impact factor:   2.401


  34 in total

1.  Perinatal factors and mortality from breast cancer.

Authors:  Maureen Sanderson; Janet R Daling; David R Doody; Kathleen E Malone
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2006-10       Impact factor: 4.254

2.  Male pseudohermaphroditism due to testicular 17 -hydroxysteroid dehydrogenase deficiency.

Authors:  U Goebelsmann; R Horton; J H Mestman; J J Arce; Y Nagata; R M Nakamura; I H Thorneycroft; D R Mishell
Journal:  J Clin Endocrinol Metab       Date:  1973-05       Impact factor: 5.958

3.  Urinary oestriol excretion in twin pregnancies.

Authors:  D B Duff; J B Brown
Journal:  J Obstet Gynaecol Br Commonw       Date:  1974-09

4.  Studies of cancer etiology in the Danish twin population. I. Breast cancer.

Authors:  N V Holm
Journal:  Prog Clin Biol Res       Date:  1981

5.  Plasma steroid changes in twin pregnancies.

Authors:  R L TambyRaja; S S Ratnam
Journal:  Prog Clin Biol Res       Date:  1981

Review 6.  Pregnancy characteristics and maternal breast cancer risk: a review of the epidemiologic literature.

Authors:  Sarah Nechuta; Nigel Paneth; Ellen M Velie
Journal:  Cancer Causes Control       Date:  2010-03-12       Impact factor: 2.506

7.  Intrauterine environment and breast cancer risk in women: a population-based study.

Authors:  A Ekbom; C C Hsieh; L Lipworth; H Q Adami; D Trichopoulos
Journal:  J Natl Cancer Inst       Date:  1997-01-01       Impact factor: 13.506

8.  Maternal plasma concentrations of insulin-like growth factor-I (IGF-I) and human placental lactogen (hPL) in twin pregnancies.

Authors:  R R Kazer; E R Cheng; T G Unterman; R P Glick
Journal:  Acta Genet Med Gemellol (Roma)       Date:  1991

9.  Serum insulin-like growth factor-binding protein-3 (IGFBP-3) levels and IGFBP-3 protease activity in normal, abnormal, and multiple human pregnancy.

Authors:  K S Langford; K H Nicolaides; J Jones; A Abbas; A M McGregor; J P Miell
Journal:  J Clin Endocrinol Metab       Date:  1995-01       Impact factor: 5.958

Review 10.  Hormonal regulation of the hypothalamic melanocortin system.

Authors:  Jung D Kim; Stephanie Leyva; Sabrina Diano
Journal:  Front Physiol       Date:  2014-12-09       Impact factor: 4.566

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.